SONOCO PRODUCTS CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SONOCO PRODUCTS CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.52B | Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | $1.36B | Feb 28, 2025 |
| FY2024 | Sep 29, 2024 | $1.35B | Feb 28, 2025 |
| FY2024 | Jun 30, 2024 | $1.28B | Feb 28, 2025 |
| FY2024 | Mar 31, 2024 | $1.31B | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | $1.34B | Feb 28, 2025 |
| FY2024 | Oct 1, 2023 | $1.38B | Feb 28, 2025 |
| FY2024 | Jul 2, 2023 | $1.34B | Feb 28, 2025 |
| FY2024 | Apr 2, 2023 | $1.39B | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | $5.86B | Feb 28, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.52B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $5.31B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.44B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $5.38B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $5.59B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $5.24B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $1.31B | Feb 28, 2020 |
| FY2019 | Sep 29, 2019 | $1.35B | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $1.36B | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $1.35B | Feb 28, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.30B | Feb 28, 2018 |
| FY2017 | Oct 1, 2017 | $1.32B | Feb 28, 2018 |
| FY2017 | Jul 2, 2017 | $1.24B | Feb 28, 2018 |
| FY2017 | Apr 2, 2017 | $1.17B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $1.14B | Feb 28, 2018 |
| FY2017 | Oct 2, 2016 | $1.21B | Feb 28, 2018 |
| FY2017 | Jul 3, 2016 | $1.21B | Feb 28, 2018 |
| FY2017 | Apr 3, 2016 | $1.23B | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $1.27B | Mar 1, 2017 |
| FY2016 | Sep 27, 2015 | $1.24B | Mar 1, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.57B | Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | $282.97M | Feb 28, 2025 |
| FY2024 | Sep 29, 2024 | $299.75M | Feb 28, 2025 |
| FY2024 | Jun 30, 2024 | $285.30M | Feb 28, 2025 |
| FY2024 | Mar 31, 2024 | $271.22M | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | $287.98M | Feb 28, 2025 |
| FY2024 | Oct 1, 2023 | $307.85M | Feb 28, 2025 |
| FY2024 | Jul 2, 2023 | $291.95M | Feb 28, 2025 |
| FY2024 | Apr 2, 2023 | $314.80M | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | $1.23B | Feb 28, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.00B | Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | ($42.96M) | Feb 28, 2025 |
| FY2024 | Sep 29, 2024 | $50.92M | Feb 28, 2025 |
| FY2024 | Jun 30, 2024 | $90.81M | Feb 28, 2025 |
| FY2024 | Mar 31, 2024 | $65.18M | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | $81.24M | Feb 28, 2025 |
| FY2024 | Oct 1, 2023 | $130.75M | Feb 28, 2025 |
| FY2024 | Jul 2, 2023 | $114.65M | Feb 28, 2025 |
| FY2024 | Apr 2, 2023 | $148.32M | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | $466.44M | Feb 28, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $326.58M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $589.05M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $563.36M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $486.85M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $357.80M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $467.08M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $437.63M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $412.41M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $504.64M | Feb 28, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $23.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $23.90M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $23.10M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $24.10M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $22.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $23.30M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $23.20M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $21.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $22.50M | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $862.18M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $723.83M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $644.54M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $609.58M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $558.18M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $528.44M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $530.87M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $563.31M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $507.82M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $503.05M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $689.78M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $833.85M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $882.92M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $509.05M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $298.67M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $705.62M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $425.85M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $589.90M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $348.25M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $398.68M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $344.02M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $393.24M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $363.08M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $328.77M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $256.02M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $194.13M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $195.93M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $192.57M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $188.91M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $186.74M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.16B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $12.51B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $7.19B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $7.05B | Feb 28, 2024 |
| FY2023 | Dec 31, 2021 | $5.07B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $5.28B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $5.13B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $4.58B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $4.56B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $3.92B | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.53B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $10.22B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $4.76B | Feb 28, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.61B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.27B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.42B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.07B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.84B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.90B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.80B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.76B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.71B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.53B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.51B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.53B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.30B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.68B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.32B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.39B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.43B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.31B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.24B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.09B | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.38B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.58B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.62B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.35B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.07B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $2.34B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $2.30B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $2.19B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $2.04B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.94B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $378.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $431.01M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $138.90M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $227.44M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $170.98M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $564.85M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $145.28M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $120.39M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $254.91M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $257.23M | Feb 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $1.39B | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | $1.45B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.05B | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $1.13B | Mar 1, 2017 |
| FY2015 | Dec 31, 2014 | $1.25B | Feb 29, 2016 |
| FY2014 | Dec 31, 2013 | $981.46M | Aug 26, 2015 |
| FY2013 | Dec 31, 2012 | $1.37B | Mar 3, 2014 |
| FY2012 | Dec 31, 2011 | $1.29B | Mar 1, 2013 |
| FY2011 | Dec 31, 2010 | $620.89M | Feb 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Sep 29, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Feb 28, 2025 |
| FY2024 | Oct 1, 2023 | 1 | Feb 28, 2025 |
| FY2024 | Jul 2, 2023 | 1 | Feb 28, 2025 |
| FY2024 | Apr 2, 2023 | 1 | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | 4 | Feb 28, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Sep 29, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Feb 28, 2025 |
| FY2024 | Oct 1, 2023 | 1 | Feb 28, 2025 |
| FY2024 | Jul 2, 2023 | 1 | Feb 28, 2025 |
| FY2024 | Apr 2, 2023 | 1 | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | 4 | Feb 28, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 98.63M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 98.26M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 97.96M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 97.65M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 97.37M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 100.45M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 100.20M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 99.83M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 99.41M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 99.19M | Feb 28, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $208.11M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $203.49M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $197.42M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $187.09M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $178.62M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $172.63M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $170.25M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $161.43M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $153.14M | Feb 28, 2020 |